Still in Pain After Anti-inflammatory Meds and Rehab? When to Consider C-TAME Microvascular Embolization
Still in Pain After Anti-inflammatory Meds and Rehab? When to Consider C-TAME Microvascular Embolization
Article Summary
You've taken anti-inflammatory painkillers for a while and done physical therapy for months, yet the pain persists. At this point, many people wonder: "Is it time for C-TAME?"
Not necessarily. At Shi-Yi Clinic, evaluating suitability for C-TAME (Catheter-directed Transcatheter Arterial Microembolization) requires meeting three criteria: pain lasting more than three months, limited response to conservative treatments like anti-inflammatory medications and physical therapy, and imaging showing that the pain source is related to abnormal neovascularization. All three must be met before an evaluation proceeds. Even if these criteria are met, vascular anatomy, procedural risks, and alternative options must still be assessed before determining whether to recommend the procedure.
This article explains "when it is appropriate to be evaluated." For the differences between the two embolization approaches, please see "What is the Difference Between C-TAME and s-TAME?"; for medical history and risks requiring special attention, please see "Who is Not Suitable for TAME Microembolization?"; for the overall sequence of treatments, please see "What Are the Treatment Options for Chronic Pain?".
Why Does It Still Hurt After Medications and Physical Therapy?
Anti-inflammatory analgesics and physical therapy each serve distinct roles and are typically the first-line treatments considered for musculoskeletal pain. Medications help alleviate inflammation and pain; physical therapy works to improve muscle strength, range of motion, and movement patterns based on the condition, progressively restoring daily functioning. Most individuals recover during this phase.
If pain persists after treatment, several factors must be re-evaluated: whether the initially identified source of pain was accurate, whether the current treatment approach is appropriate, and whether other concurrent causes of pain exist. Degeneration or inflammation observed on imaging may not fully explain all pain symptoms; similarly, experiencing a recurrence of pain after brief relief is not sufficient on its own to determine the next therapeutic step.
Studies of degenerated joint tissues have observed neovascularization accompanied by nerve ingrowth, which forms part of the rationale behind microembolization research. However, the presence of increased vascularity on imaging does not independently prove it is the source of pain, nor does it directly imply that "limited response to medication and physical therapy makes one suitable for embolization."
Additionally, nonsteroidal anti-inflammatory drugs (NSAIDs) can cause gastrointestinal discomfort, carry risks of gastric ulcers, bleeding, and may affect renal function. If continued medication use is necessary, discuss the dosage, duration, and alternative options with your physician. Do not increase the dose or combine different anti-inflammatory painkillers on your own.
Why Use Three Months as the Threshold?
The ICD-11 classification of chronic pain proposed by the International Association for the Study of Pain (IASP) defines chronic pain as pain that persists or recurs for more than three months. This timeframe helps identify pain conditions that require continued evaluation and management.
Three months does not imply that all tissues should be fully healed by this time, nor is it a scientifically proven optimal window for embolization. At Shi-Yi Clinic, it serves as a clinical threshold to re-examine the disease course and treatment response: first identifying why pain persists before discussing appropriate treatments.
If pain is already affecting your daily life or if new symptoms emerge, there is no need to wait for three months before seeking medical care. Conversely, having pain for over three months does not automatically mean that C-TAME is required.
Shi-Yi Clinic's Three Criteria for C-TAME Evaluation
Criterion 1: Pain persisting for more than three months. For acute pain or pain with a shorter duration, the cause is typically investigated first, with conservative treatments arranged according to the condition; if more urgent issues are present, patients are promptly referred for corresponding evaluation and treatment.
Criterion 2: Limited response to conservative treatment. The physician will review the treatments previously received, their duration, and the degree of improvement in pain and daily function. Anti-inflammatory medications, physical therapy, shockwave therapy, or local injections can all be components of conservative care, but it is not necessary to try every single modality before qualifying for a re-evaluation. A pattern of "improving after treatment, but with progressively shorter relief intervals" is also worth discussing with your physician; multiple underlying causes may exist, necessitating a thorough re-diagnosis.
Criterion 3: Imaging indicating the source of pain is associated with abnormal neovascularization. The physician will synthesize medical history, pain localization, palpation, motion-provoked symptoms, and imaging findings. X-rays primarily assess bone and joint architecture; ultrasound helps evaluate soft tissues and blood flow, with additional imaging arranged if needed. The focus is on determining comprehensively whether there are vascular targets worth further evaluation while ruling out conditions requiring higher priority, rather than relying on a single image alone.
Conditions currently more frequently discussed in the literature include knee osteoarthritis, frozen shoulder (adhesive capsulitis), and certain tendinopathies or enthesopathies. The volume and quality of research vary considerably across different anatomical sites, and findings from one site cannot be directly extrapolated to all forms of chronic pain.
These three criteria serve as guiding evaluation principles at Shi-Yi Clinic, not a deterministic formula guaranteeing efficacy once met.
In Which Cases Is C-TAME Evaluation Not Recommended Initially?
In the following situations, other issues generally need to be clarified first, or necessary risk assessments completed:
Pain still in the acute stage, or the disease course is under three months. The underlying cause should be identified first, with conservative treatment and follow-up arranged; if red-flag symptoms are present, seek prompt medical attention.
The source of pain remains unconfirmed. Clarify the root cause before discussing whether embolization is needed; for details, please refer to "Still in Pain After Six Months of Physical Therapy and Told Surgery Isn't Needed?".
Presence of neurological symptoms such as numbness or weakness. An assessment should first determine whether nerve compression or other neurological conditions are involved; C-TAME cannot replace this diagnostic and therapeutic process. If back pain or lower limb neurological symptoms are accompanied by new-onset urinary retention, fecal/urinary incontinence, or saddle anesthesia, go to the emergency department immediately.
Imaging and clinical symptoms indicating structural damage or compression that requires prioritized intervention, or the presence of distinct, progressively worsening neurological deficits. An evaluation by the appropriate specialist should be sought first, with surgical management considered if necessary.
A history of allergies to contrast agents or related medications, impaired renal function, or current use of anticoagulant or antiplatelet therapies. These circumstances require individualized risk assessment and tailored approaches; please proactively share your medical history and medication details, and do not stop medications on your own. Embolization may also not be advised if vascular anatomy or blood supply configurations do not permit a safe procedure. For details, see "Who is Not Suitable for TAME Microembolization?".
Expecting a single treatment to resolve all pain. It is advised to clarify treatment goals and limitations with your physician beforehand; therapeutic outcomes vary by individual, anatomical site, and disease status, and improvements may be modest. Complete relief or prevention of recurrence cannot be guaranteed.
What Is the Clinical Diagnosis and Evaluation Process?
The initial consultation begins with a review of your pain progression, current symptoms, prior treatments, and current medications, followed by a physical examination. X-rays, ultrasound, or other imaging modalities may be ordered as necessary. Some evaluations can be completed on the same day, depending on the clinical condition and scheduling. The physician will integrate the medical history, diagnostic findings, and treatment responses to discuss likely pain generators as well as any unresolved questions requiring clarification.
Following the evaluation, three pathways are possible.
First, if the comprehensive assessment supports further evaluation of abnormal vessels and is suitable for a transcatheter approach, the physician will discuss C-TAME. Once entering this stage, catheter pathways, blood supply to surrounding normal tissues, and procedural risks must still be weighed; angiography can be used to further identify target vessels and assess the safety and feasibility of embolization. This does not mean every newly evaluated patient requires invasive angiography from the outset.
Second, if the target feeding artery is superficial and can be clearly visualized under ultrasound, the physician may discuss s-TAME—a direct fine-needle puncture into the artery under ultrasound guidance to administer the agent without catheter placement. While clinical series have been published for conditions like plantar fasciitis, these studies lack control groups, and outcomes from catheter-based procedures cannot be directly assumed for this technique.
Third, neither procedure is recommended. If no suitable vascular target is found, if procedural risks outweigh potential benefits, or if other therapeutic options are better suited, the physician will explain the rationale and recommend subsequent care plans.
The decision between C-TAME and s-TAME depends primarily on the feeding vessel's location and depth relative to the pain source, ultrasound visualizability, viable access routes, and the current state of clinical evidence for the specific anatomical site. For detailed differences and procedural workflows, see "What is the Difference Between C-TAME and s-TAME?".
Currently, both C-TAME and s-TAME are self-pay procedures. Costs vary depending on the treatment site, extent, and method utilized, and will be explained prior to treatment following the evaluation.
What Does the Current Evidence Show?
Relevant medical literature frequently uses terms such as "Transcatheter Arterial Embolization (TAE)" or "Genicular Artery Embolization (GAE)." Because studies employ varied embolic agents, anatomical targets, and patient selection criteria, findings must be interpreted separately, and catheter-based evidence cannot be directly applied as proof of efficacy for s-TAME.
Early research includes studies by Dr. Yuji Okuno's team on tendinopathy and enthesopathy published in 2013, a 2014 pilot study on frozen shoulder, and a 2017 follow-up study on knee osteoarthritis. These studies observed improvements in pain and function in some patients; however, most were small, single-center studies without control groups, making it difficult to fully rule out natural disease progression, co-interventions, or placebo effects.
Regarding frozen shoulder, a study published in 2025 also reported post-treatment improvements in pain and function, similarly lacking a control group.
Therefore, this therapy is currently best positioned as "an option open to discussion after appropriate screening, with an evidence base that is still accumulating." Deciding whether it is worthwhile requires balancing symptom impact on daily life, response to prior treatments, site-specific clinical evidence, and procedural risks.
How Can You Prepare Before Visiting Shi-Yi Clinic for Evaluation?
If your pain has persisted for more than three months with limited relief from anti-inflammatory drugs, physical therapy, or injections, you can first contact Shi-Yi Clinic via our official LINE to provide details on your pain location, duration, prior treatments, treatment responses, and current medications before inquiring about appointment scheduling.
For your visit, please bring prior imaging records and reports (e.g., X-rays, MRI, ultrasound), as well as past treatment records and current medication lists. For a detailed checklist, please see "What to Prepare for Your First Pain Clinic Visit?".
Shi-Yi Clinic is located at 2F-1, No. 40, Sec. 2, Heping E. Rd., Daan District, Taipei City. Consultations are strictly by appointment. Phone: (02) 2366-0186.
Authored by: Dr. Ping-Sheng Lu, Dr. Yu-Chieh Wu
Last updated: October 17, 2026
Disclaimer: This article provides health educational information and is not a substitute for professional medical diagnosis and treatment advice. Suitability for any treatment must be determined through evaluation by a physician.
References
Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27. doi:10.1097/j.pain.0000000000001384
Okuno Y, Matsumura N, Oguro S. Transcatheter arterial embolization using imipenem/cilastatin sodium for tendinopathy and enthesopathy refractory to nonsurgical management. J Vasc Interv Radiol. 2013;24(6):787-792. doi:10.1016/j.jvir.2013.02.033
Okuno Y, Oguro S, Iwamoto W, Miyamoto T, Ikegami H, Matsumura N. Short-term results of transcatheter arterial embolization for abnormal neovessels in patients with adhesive capsulitis: a pilot study. J Shoulder Elbow Surg. 2014;23(9):e199-e206. doi:10.1016/j.jse.2013.12.014
Okuno Y, Korchi AM, Shinjo T, Kato S, Kaneko T. Midterm clinical outcomes and MR imaging changes after transcatheter arterial embolization as a treatment for mild to moderate radiographic knee osteoarthritis resistant to conservative treatment. J Vasc Interv Radiol. 2017;28(7):995-1002. doi:10.1016/j.jvir.2017.02.033
Liang KW, Lin HY, Hsu KL, et al. Clinical and radiological outcomes of transarterial embolization for adhesive capsulitis. Korean J Radiol. 2025;26(3):230-238. doi:10.3348/kjr.2024.0883
Sasaki T, Shibuya M, Miyazaki K, et al. Clinical results of ultrasound-guided intra-arterial embolization targeting abnormal neovessels for plantar fasciitis: 66 cases with up to 4 years of follow-up. Foot Ankle Surg. 2025;31(2):105-110. doi:10.1016/j.fas.2024.07.009
Ashraf S, Wibberley H, Mapp PI, Hill R, Wilson D, Walsh DA. Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis. Ann Rheum Dis. 2011;70(3):523-529. doi:10.1136/ard.2010.137844
De Marchi A, Pozza S, Cenna E, et al. In Achilles tendinopathy, the neovascularization, detected by contrast-enhanced ultrasound (CEUS), is abundant but not related to symptoms. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):2051-2058. doi:10.1007/s00167-017-4710-8
National Health Service (UK). NSAIDs. Page last reviewed 28 April 2026. https://www.nhs.uk/conditions/nsaids/
